Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $1.60 billion. The enterprise value is $1.66 billion.
| Market Cap | 1.60B |
| Enterprise Value | 1.66B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 358.55 million shares outstanding. The number of shares has increased by 34.42% in one year.
| Current Share Class | 358.55M |
| Shares Outstanding | 358.55M |
| Shares Change (YoY) | +34.42% |
| Shares Change (QoQ) | +1.81% |
| Owned by Insiders (%) | 11.69% |
| Owned by Institutions (%) | 39.61% |
| Float | 195.12M |
Valuation Ratios
The trailing PE ratio is 65.92 and the forward PE ratio is 6.79.
| PE Ratio | 65.92 |
| Forward PE | 6.79 |
| PS Ratio | 10.21 |
| Forward PS | 4.67 |
| PB Ratio | 19.13 |
| P/TBV Ratio | 24.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 67.82 |
| EV / Sales | 10.55 |
| EV / EBITDA | 43.47 |
| EV / EBIT | 49.22 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.58, with a Debt / Equity ratio of 1.18.
| Current Ratio | 5.58 |
| Quick Ratio | 4.63 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 2.46 |
| Debt / FCF | n/a |
| Interest Coverage | 2.85 |
Financial Efficiency
Return on equity (ROE) is 38.84% and return on invested capital (ROIC) is 27.79%.
| Return on Equity (ROE) | 38.84% |
| Return on Assets (ROA) | 10.97% |
| Return on Invested Capital (ROIC) | 27.79% |
| Return on Capital Employed (ROCE) | 18.55% |
| Weighted Average Cost of Capital (WACC) | 9.78% |
| Revenue Per Employee | $980,894 |
| Profits Per Employee | $152,531 |
| Employee Count | 160 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.08 |
Taxes
In the past 12 months, Precigen has paid $200,000 in taxes.
| Income Tax | 200,000 |
| Effective Tax Rate | 0.81% |
Stock Price Statistics
The stock price has increased by +12.03% in the last 52 weeks. The beta is 0.98, so Precigen's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +12.03% |
| 50-Day Moving Average | 6.98 |
| 200-Day Moving Average | 5.28 |
| Relative Strength Index (RSI) | 30.61 |
| Average Volume (20 Days) | 7,382,495 |
Short Selling Information
The latest short interest is 46.39 million, so 12.94% of the outstanding shares have been sold short.
| Short Interest | 46.39M |
| Short Previous Month | 47.55M |
| Short % of Shares Out | 12.94% |
| Short % of Float | 23.78% |
| Short Ratio (days to cover) | 8.53 |
Income Statement
In the last 12 months, Precigen had revenue of $156.94 million and earned $24.41 million in profits. Earnings per share was $0.07.
| Revenue | 156.94M |
| Gross Profit | 116.93M |
| Operating Income | 33.63M |
| Pretax Income | 24.61M |
| Net Income | 24.41M |
| EBITDA | 38.08M |
| EBIT | 33.63M |
| Earnings Per Share (EPS) | $0.07 |
Balance Sheet
The company has $46.07 million in cash and $98.61 million in debt, with a net cash position of -$52.54 million or -$0.15 per share.
| Cash & Cash Equivalents | 46.07M |
| Total Debt | 98.61M |
| Net Cash | -52.54M |
| Net Cash Per Share | -$0.15 |
| Equity (Book Value) | 83.79M |
| Book Value Per Share | 0.23 |
| Working Capital | 140.97M |
Cash Flow
In the last 12 months, operating cash flow was -$73.21 million and capital expenditures -$1.10 million, giving a free cash flow of -$74.32 million.
| Operating Cash Flow | -73.21M |
| Capital Expenditures | -1.10M |
| Depreciation & Amortization | 4.45M |
| Net Borrowing | -654,000 |
| Free Cash Flow | -74.32M |
| FCF Per Share | -$0.21 |
Margins
Gross margin is 74.51%, with operating and profit margins of 21.43% and 15.55%.
| Gross Margin | 74.51% |
| Operating Margin | 21.43% |
| Pretax Margin | 15.68% |
| Profit Margin | 15.55% |
| EBITDA Margin | 24.26% |
| EBIT Margin | 21.43% |
| FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -34.42% |
| Shareholder Yield | -34.42% |
| Earnings Yield | 1.52% |
| FCF Yield | -4.64% |
Analyst Forecast
The average price target for Precigen is $14.00, which is 213.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 213.20% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 275.44% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -5.35 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.35 |
| Piotroski F-Score | 5 |